神经药理学报››2011,Vol. 1››Issue (3): 16-22.

• 研究论文 •上一篇下一篇

远志总皂苷对AD模型大鼠海马nAChRα4及PSD-95表达的影响

李晓峰1,赵大鹏1,陈树沙1,景玮2,李新毅2

  1. 1.山西医科大学第一临床医学院,神经内科, 030001,太原
    2.山西医学科学院,神经内科,030031,太原
  • 出版日期:2011-06-26发布日期:2012-06-28
  • 通讯作者:李新毅,男,主任医师,神经病学/神经生理学博士,博士生导师;研究方向:老年性痴呆和脑血管病
  • 作者简介:李晓峰,男,山西医科大学在读硕士;研究方向:老年性痴呆、脑血管病;Email:xiaofengli_2011@163.com
  • 基金资助:

    国家自然科学基金项目(No.801173455)

The Effects of Tenuigenin on Expression of nAChRα4 and PSD95 in Alzheimer’s Disease Model Rats

Li Xiao-feng1,Zhao Da-peng1,Chen Shu-sha1,Jing Wei2,Li Xin-yi2

  1. 1. Department of Neurology,The First Clinical Medical School,Shanxi Medical University,Taiyuan Shanxi, 030001,China2. Shanxi Academy of Medical Science,Taiyuan, 030031,China
  • Online:2011-06-26Published:2012-06-28

摘要:目的:通过观察中药远志总皂苷(Tenuigenin,TEN)对阿尔茨海默病(Alzheimer’s disease,AD)模型大鼠烟碱型乙酰胆碱受体α4亚基(Nicotinic Acetylcholine Receptor subunit alpha-4,nAChRα4)和突触后致密蛋白95 (postsynaptic density 95,PSD-95)表达的影响,旨在探讨TEN对AD干预作用的机制。方法:32只雄性Wistar大鼠随机分为对照组,模型组,TEN 12.5,37.5 mg·mL-1剂量组,应用D-半乳糖致衰老的基础上定向Meynert基底核损毁建立AD大鼠模型,TEN12.5,37.5 mg·mL-1治疗组则在造模的同时用远志总皂苷灌胃(ig)治疗,采用免疫组化方法来检测大鼠海马CA1区nAChRα4及PSD-95的表达。结果:模型组大鼠海马CA1区nAChRα4及PSD-95平均灰度值显著高于对照组,平均光密度值显著降低(P<0.01);TEN 12.5,37.5 mg·mL-1剂量组大鼠海马nAChRα4及PSD-95平均灰度值显著低于模型组,两组平均光密度值均显著增高(P<0.05);且TEN 37.5 mg·mL-1剂量组的平均灰度值比TEN 12.5 mg·mL-1剂量组显著降低,平均光密度值显著增高(P<0.01)。结论:TEN可显著提高AD模型大鼠海马CA1区nAChRα4及PSD-95的表达,并具有剂量依赖性,这可能是其改善认知功能的部分机制。

关键词:远志总皂苷,阿尔茨海默病,海马,nAChR&,alpha,4,PSD-95

Abstract:Objective:To investigate the effects and the underlying mechanisms of Tenuigenin on Alzheimer’s disease by observing the effects of Tenuigenin(TEN) on expression of nicotinic acetylcholine receptor subunit alpha-4 (nAChRα4) and postsynaptic density 95(PSD-95) in Alzheimer’s disease model rat.Methods:32 male Wistar rats were divided randomly into four groups: control group,model group,12.5 mg·mL-1dose TEN group and 37.5 mg·mL-1dose TEN group. The rat model with Alzheimer’s disease was made by injecting ibotenic acid into Meynert basal nuclei of aging rat induced by D-gal.The expressions of nAChRα4 and PSD-95 in the hippocampus CA1 were measured by immunohistochemistry method.Results:Compared with the control group,the average gray-scale values of hippocampus CA1 nAChRα4 and PSD-95 in the model group were increased significantly and the average optical density was decreased obviously (P<0.01). Compared with the model group,the average gray-scale values in the hippocampus CA1 of 37.5 mg·mL-1dose TEN group and 12.5 mg·mL-1dose TEN group were obviously decreased and the average optical density was increased significantly (P<0.05). Meanwhile,the average gray-scale value within the hippocampus CA1 of 37.5 mg·mL-1dose TEN group was significantly less than that in 12.5 mg·mL-1dose TEN group,but more distinct than that on the average optical density aspect (P<0.01).Conclusion:TEN can dose-dependently increase the expression of CA1 area nAChRα4 and PSD-95 in Alzheimer’s disease model rats,which may partly explain the beneficial effects of TEN on cognitive function.

Key words:Tenuigenin,Alzheimer&,rsquo,s disease,hippocampus,nAChR&,alpha,4,PSD-95

中图分类号:

Baidu
map